This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Edith Cowan University. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Mel Ziman: Innovator in Melanoma Diagnosis and Treatment
Introduction
Mel Ziman is a distinguished inventor based in Sorrento, Australia. He has made significant contributions to the field of medical diagnostics, particularly in the area of melanoma. His innovative work focuses on the early detection and treatment of this serious skin cancer.
Latest Patents
Mel Ziman holds a patent related to biomarkers of disease. The patent, titled "Biomarkers of disease," outlines methods for the diagnosis and treatment of melanoma. Specifically, it details techniques for diagnosing early-stage melanoma by measuring the expression of various autoantibodies, including anti-ZBTB7B, anti-PRKCH, anti-TP53, anti-PCTK1, anti-PQBP1, anti-UBE2V1, anti-IRF4, anti-MAPK8_tv2, anti-MSN, and anti-TPM1. Additionally, the invention includes kits that comprise one or more reagents and/or devices for performing these diagnostic methods.
Career Highlights
Mel Ziman is affiliated with Edith Cowan University, where he continues to advance research in the field of melanoma. His work has garnered attention for its potential to improve early detection and treatment options for patients suffering from this disease.
Collaborations
Throughout his career, Mel has collaborated with notable colleagues, including Elin Gray and Pauline Zaenker. These partnerships have contributed to the development and refinement of his innovative diagnostic methods.
Conclusion
Mel Ziman's contributions to melanoma research and diagnostics highlight the importance of innovation in the medical field. His patented methods and collaborative efforts aim to enhance early detection and treatment, ultimately benefiting patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile